P281424/AMR
1
0
Fork 0
mirror of https://github.com/msberends/AMR.git synced 2025-07-11 21:01:54 +02:00
Code Releases Activity

(v2.1.1.9135) documentation fix

Browse Source
This commit is contained in:
dr. M.S. (Matthijs) Berends
2025-01-28 15:16:55 +01:00
parent e740aa691b
commit 700522b466
10 changed files with 18 additions and 18 deletions
Download Patch File Download Diff File Expand all files Collapse all files

8
R/antibiogram.R
View File

@ -32,7 +32,7 @@
#' @description
#' Create detailed antibiograms with options for traditional, combination, syndromic, and Bayesian WISCA methods.
#'
#' Adhering to previously described approaches (see *Source*) and especially the Bayesian WISCA model (Weighted-Incidence Syndromic Combination Antibiogram) by Bielicki *et al.*, these functions provides flexible output formats including plots and tables, ideal for integration with R Markdown and Quarto reports.
#' Adhering to previously described approaches (see *Source*) and especially the Bayesian WISCA model (Weighted-Incidence Syndromic Combination Antibiogram) by Bielicki *et al.*, these functions provide flexible output formats including plots and tables, ideal for integration with R Markdown and Quarto reports.
#' @param x a [data.frame] containing at least a column with microorganisms and columns with antimicrobial results (class 'sir', see [as.sir()])
#' @param antibiotics vector of any antimicrobial name or code (will be evaluated with [as.ab()], column name of `x`, or (any combinations of) [antimicrobial selectors][antimicrobial_class_selectors] such as [aminoglycosides()] or [carbapenems()]. For combination antibiograms, this can also be set to values separated with `"+"`, such as "TZP+TOB" or "cipro + genta", given that columns resembling such antimicrobials exist in `x`. See *Examples*.
#' @param mo_transform a character to transform microorganism input - must be `"name"`, `"shortname"` (default), `"gramstain"`, or one of the column names of the [microorganisms] data set: `r vector_or(colnames(microorganisms), sort = FALSE, quotes = TRUE)`. Can also be `NULL` to not transform the input.
@ -54,9 +54,9 @@
#' @param info a [logical] to indicate info should be printed - the default is `TRUE` only in interactive mode
#' @param object an [antibiogram()] object
#' @param ... when used in [R Markdown or Quarto][knitr::kable()]: arguments passed on to [knitr::kable()] (otherwise, has no use)
#' @details This function returns a table with values between 0 and 100 for *susceptibility*, not resistance.
#' @details These functions return a table with values between 0 and 100 for *susceptibility*, not resistance.
#'
#' **Remember that you should filter your data to let it contain only first isolates!** This is needed to exclude duplicates and to reduce selection bias. Use [first_isolate()] to determine them in your data set with one of the four available algorithms.
#' **Remember that you should filter your data to let it contain only first isolates!** This is needed to exclude duplicates and to reduce selection bias. Use [first_isolate()] to determine them with one of the four available algorithms: isolate-based, patient-based, episode-based, or phenotype-based.
#'
#' For estimating antimicrobial coverage, especially when creating a WISCA, the outcome might become more reliable by only including the top *n* species encountered in the data. You can filter on this top *n* using [top_n_microorganisms()]. For example, use `top_n_microorganisms(your_data, n = 10)` as a pre-processing step to only include the top 10 species in the data.
#'
@ -225,7 +225,7 @@
#'
#' For hierarchical modelling, pathogen-level effects (e.g., differences in resistance patterns) and regimen-level effects are modelled using Gaussian priors on log-odds. This hierarchical structure ensures partial pooling of estimates across groups, improving stability in strata with small sample sizes. The model is implemented using Hamiltonian Monte Carlo (HMC) sampling.
#'
#' Stratified results can be provided based on covariates such as age, sex, and clinical complexity (e.g., prior antimicrobial treatments or renal/urological comorbidities) using `dplyr`'s [group_by()] as a pre-processing step before running [wisca()]. In this case, posterior odds ratios (ORs) are derived to quantify the effect of these covariates on coverage probabilities:
#' Stratified results can be provided based on covariates such as age, sex, and clinical complexity (e.g., prior antimicrobial treatments or renal/urological comorbidities) using `dplyr`'s [`group_by()`][dplyr::group_by()] as a pre-processing step before running [wisca()]. Posterior odds ratios (ORs) are derived to quantify the effect of these covariates on coverage probabilities:
#'
#' \deqn{\text{OR}_{\text{covariate}} = \frac{\exp(\beta_{\text{covariate}})}{\exp(\beta_0)}}
#'